Advances in Cancer Clinical Trials

Print icon

It’s frightening to receive a cancer diagnosis. But there is more hope than ever before: clinical trials have been a key part of cancer patients living longer with better outcomes. Dr. Peter Yu is physician-in-chief at the Hartford HealthCare Cancer Institute, a charter member of the Memorial Sloan Kettering Cancer Alliance. He talks about the importance of cancer clinical trials, and what they mean for cancer care, both now and in the future. 

Q: What is the impact of clinical research – particularly cancer clinical trials – in patient treatment today?

A: There are more patients being cured and living longer than ever before. But that’s a testament to the clinical trials that have been going on for the past few decades. Without those clinical trials, we would not have the treatments that are working so well today. And we need to continue to do clinical trials because we need to continue to have better treatments and have patients live longer and with better quality of life.

Q: What is your response to patients and their family members who may be afraid of the phrase “clinical trial?”

A: I would say the number one worry that people have about clinical trials is placebo. They will ask “How do I know that I’m not gonna get some dummy treatment or sugar pill?”

The fact of the matter is that that is very, very rare today because of all the successes we’ve had in treatment. So it’s almost unthinkable that there would be no option whatsoever. What we often do today is a randomization, where the patient will get some treatment versus some experimental treatment. And that some treatment is what we call the current standard of care, or the best available care to our knowledge, but it’s usually not the best treatment that we hope to have someday. Every patient with cancer, working together with their healthcare team, with other patients around the country to advance cures.

Learn more about the clinical cancer trials available through the Hartford HealthCare Cancer Institute alliance with Memorial Sloan Kettering Cancer Center here

What's New


Why People, And Medical Researchers, Need Help with Anger

Anger is the first negative emotion babies can express and research shows that as many people seek treatment for it as depression and anxiety combined. Yet it is not officially classified a mental health disorder which, according to Dr. Ray DiGuiseppe, director of education with the Albert Ellis Institute and...

High Preparedness: Legal or Not, What’s Weed Do to Drivers?

Dr. Godfrey Pearlson Director, Olin Neuropsychiatry Research Center at the Institute of Living Research Director, Institute of Living Hartford HealthCare Behavioral Health Network Whatever the outcome of the current debate on legalizing recreational marijuana in Connecticut, we need to know more about marijuana’s overall effect on the brain and behavior...

Stress and Your Heart

Study: Stress-Related Disorder Heightens Heart Risk

People have a 60 percent increased risk of cardiovascular disease within the first year of being diagnosed with any stress-related disorder, according to a new study in Sweden. The results, published April 10 in the British Medical Journal, used data from the Swedish National Patient Register to compare people diagnosed...

Joint Replacement Surgery

Why a Partial Knee Replacement is Same-Day Surgery

Doctors at the Hartford HealthCare Bone & Joint Institute at Hartford Hospital are using new technology to customize joint replacements, making recovery easier. Here’s more from Dr. Mark Shekhman, a Bone & Joint Institute orthopedic surgeon: Q: At the bone and joint institute you use tools to assess the best route...